SSG
ALXN

Summit Securities Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Summit Securities Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,800
Closed -$539K – 293
2020
Q2 		$539K Buy
+4,800
New +$539K 0.07% 69
2013
Q4 		– Sell
-300
Closed -$35K – 500
2013
Q3 		$35K Buy
+300
New +$35K 0.01% 189